The growing number of studies on albumin NPs as carriers of anti-tumor drugs has led to the development of various methods for drug–albumin conjugation and discovery of many new drugs that can be conjugated with albumin to form NPs, enhancing their anti-tumor activity and targeting. Here, ALB is linked to neoplasm.